UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease

Neurology, 1999-04, Vol.52 (6), p.1158-1158

1999

Volltextzugriff (PDF)

Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration : Tau pathologies with exclusively exon 10 isoforms

Journal of neurochemistry, 1999-03, Vol.72 (3), p.1243-1249

1999

Volltextzugriff (PDF)

Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease

Neurology, 2005-11, Vol.65 (10), p.1636-1638

2005

Volltextzugriff (PDF)

Biochemical Staging of Synucleinopathy and Amyloid Deposition in Dementia With Lewy Bodies

Journal of neuropathology and experimental neurology, 2006-03, Vol.65 (3), p.278-288

2006

Volltextzugriff (PDF)

Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities

Human molecular genetics, 2001-11, Vol.10 (23), p.2717-2726

2001

Volltextzugriff (PDF)

Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation

Annals of neurology, 1998-02, Vol.43 (2), p.193-204

1998

Volltextzugriff (PDF)

Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease

Neurology, 2002-08, Vol.59 (3), p.398-407

2002

Volltextzugriff (PDF)

Tau pathology: a marker of neurodegenerative disorders

Current opinion in neurology, 2000-08, Vol.13 (4), p.371-376

2000

Volltextzugriff (PDF)

Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats

Experimental neurology, 2008-04, Vol.210 (2), p.467-478

2008

Volltextzugriff (PDF)

From physiopathology to treatment of Alzheimer's disease

Revue neurologique, 2006-10, Vol.162 (10), p.909

Delacourte, A

2006

Volltextzugriff (PDF)

Neuroimaging outcomes in clinical trials in Alzheimer’s disease

The Journal of nutrition, health & aging, 2009-03, Vol.13 (3), p.209-212

2009

Volltextzugriff (PDF)

De la physiopathologie au traitement de la maladie d’Alzheimer

Revue neurologique, 2006-10, Vol.162 (10), p.909-912

Delacourte, A.

2006

Volltextzugriff (PDF)

Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells

Journal of neuroscience research, 2001-02, Vol.63 (3), p.257-267

2001

Volltextzugriff (PDF)

Proteasome inhibition and Tau proteolysis: an unexpected regulation

FEBS letters, 2005-01, Vol.579 (1), p.1-5

2005

Volltextzugriff (PDF)

Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease

Molecular psychiatry, 2004-12, Vol.9 (12), p.1122-1128

2004

Volltextzugriff (PDF)

Association of atp synthase α-chain with neurofibrillary degeneration in alzheimer’s disease

Neuroscience, 2003-01, Vol.117 (2), p.293-303

2003

Volltextzugriff (PDF)

Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders

Acta neuropathologica, 1994-05, Vol.87 (5), p.469-480

1994

Volltextzugriff (PDF)

Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments

Journal of the neurological sciences, 1986-12, Vol.76 (2), p.173-186

1986

Volltextzugriff (PDF)

The molecular parameters of tau pathology. Tau as a killer and a witness

Advances in experimental medicine and biology, 2001, Vol.487, p.5

Delacourte, A

2001

Volltextzugriff (PDF)

Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP-17 and Pick's Disease

Brain pathology (Zurich, Switzerland), 1999-10, Vol.9 (4), p.681-693

1999

Volltextzugriff (PDF)

Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration

Biomedicine & pharmacotherapy, 1994, Vol.48 (7), p.287-295

Delacourte, A.

1994

Volltextzugriff (PDF)

Specific tau variants in the brains of patients with myotonic dystrophy

Neurology, 1996-09, Vol.47 (3), p.711-717

1996

Volltextzugriff (PDF)

Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases

Acta neuropathologica, 1992-12, Vol.85 (1), p.23-30

1992

Volltextzugriff (PDF)

Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases

FEBS letters, 1997-08, Vol.412 (3), p.578-582

1997

Volltextzugriff (PDF)

Neurosteroid Quantification in Human Brain Regions: Comparison between Alzheimer’s and Nondemented Patients

The journal of clinical endocrinology and metabolism, 2002-11, Vol.87 (11), p.5138-5143

2002

Volltextzugriff (PDF)

1 – 25 von 388

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(334)
Mit Volltextzugriff
(308)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease

Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration : Tau pathologies with exclusively exon 10 isoforms

Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease

Biochemical Staging of Synucleinopathy and Amyloid Deposition in Dementia With Lewy Bodies

Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities

Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation

Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease

Tau pathology: a marker of neurodegenerative disorders

Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats

From physiopathology to treatment of Alzheimer's disease

Neuroimaging outcomes in clinical trials in Alzheimer’s disease

De la physiopathologie au traitement de la maladie d’Alzheimer

Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells

Proteasome inhibition and Tau proteolysis: an unexpected regulation

Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease

Association of atp synthase α-chain with neurofibrillary degeneration in alzheimer’s disease

Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders

Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments

The molecular parameters of tau pathology. Tau as a killer and a witness

Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP-17 and Pick's Disease

Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration

Specific tau variants in the brains of patients with myotonic dystrophy

Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases

Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases

Neurosteroid Quantification in Human Brain Regions: Comparison between Alzheimer’s and Nondemented Patients

Suchergebnisse filtern